United Kingdom

People: Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

7:15pm BST
Change (% chg)

$-0.02 (-0.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cloutier, Gilles 

Dr. Gilles Cloutier, Ph.D., is an Independent Director of Theratechnologies Inc. Dr. Cloutier has over 30 years of experience in the pharmaceutical industry including five years with contract research organizations, providing strategic support to biotechnology and pharmaceutical companies. Dr. Cloutier has also held key positions with large North-American pharmaceutical companies, where he developed expertise in the field of clinical research. His experience includes the development and approval of several drugs in Canada, the United States and Europe. Dr. Cloutier sits on the board of the Corporation and is also a director on the board of the Fondation Innovation Vie.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --